Cyclerion Therapeutics's total assets for Q3 2025 were $10.41M, a decrease of ― from the previous quarter. CYCN total liabilities were $877.00K for the fiscal quarter, a ― a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.